CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4 Open-market sale EVP, Chief Legal Officer sold 10,044 shares at $0.72 ($7,232)
- 4 Open-market sale EVP, CFO sold 6,679 shares at an average $0.72 ($4,810)
- 4 Open-market sale EVP, Global Head RA & Quality sold 3,879 shares at $0.72 ($2,793)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award President and CEO acquired 1,280,000 shares (grant or award)
- 4 Grant or award EVP, Chief Sci. & Tech Officer acquired 675,000 shares (grant or award)
- 4 Grant or award EVP, Chief Legal Officer acquired 475,000 shares (grant or award)
- 4 Grant or award EVP, CFO acquired 475,000 shares (grant or award)
Page 11 of 57 · 1,133 filings